SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-232481
Filing Date
2023-09-11
Accepted
2023-09-11 16:16:52
Documents
14
Period of Report
2023-09-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d523866d8k.htm   iXBRL 8-K 31042
2 EX-10.1 d523866dex101.htm EX-10.1 20989
6 GRAPHIC g523866g0911221337624.jpg GRAPHIC 3137
  Complete submission text file 0001193125-23-232481.txt   191947

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mirm-20230911.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20230911_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20230911_pre.xml EX-101.PRE 11708
8 EXTRACTED XBRL INSTANCE DOCUMENT d523866d8k_htm.xml XML 3470
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 231247952
SIC: 2834 Pharmaceutical Preparations